ANDREA WALSH: Open Payments
NPI 1376992503 · EMMETT, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$85 in 5 payments from 5 companies in 2025. Trend: 2023 $560 · 2024 $247 · 2025 $85
Food & beverage: $85
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
| Boston Scientific Corporation | 1 | $15 |
| Medtronic, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, General - Pain Management, INCEPTIV.
Industry payments across ID — which companies pay providers there.
